Otitis Media Studies Can Use Four Trial Designs Under FDA Draft Guidance
FDA's draft guidance for developing drugs to treat acute bacterial otitis media offers sponsors four possible superiority study designs
You may also be interested in...
While it drops an invasive enrollment assay requirement, the revised guidance for drugs that fight childhood ear infections provides a clear path to getting pathogens targeted by an investigational anti-infective into labeling.
Industry has provided little data supporting the use of non-inferiority trials as the basis for approval for community-acquired pneumonia, FDA Office of Medical Policy Director Bob Temple said at a recent workshop on clinical trial design for CAP
Drug manufacturers made a pledge to contribute $80 bil. in a mix of savings and revenue-raising initiatives to help fund health reform. In return, they could see a wide range of new business depending on how you look at the numbers.